Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Rallybio (RLYB) EBITDA Margin (2024 - 2026)

Rallybio's EBITDA Margin history spans 2 years, with the latest figure at 2638.74% for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 2669021.0% to 2638.74% in Q4 2025 year-over-year; TTM through Dec 2025 was 1052.21%, a 802357.0% increase, with the full-year FY2025 number at 1052.21%, up 802357.0% from a year prior.
  • EBITDA Margin hit 2638.74% in Q4 2025 for Rallybio, down from 7558.02% in the prior quarter.
  • Over the last five years, EBITDA Margin for RLYB hit a ceiling of 7558.02% in Q3 2025 and a floor of 29328.95% in Q4 2024.